The article titled, "Posttransplant
Intramuscular Injection of PLX-R18 Mesenchymal-Like Adherent Stromal Cells Improves Human Hematopoietic Engraftment in A Murine Transplant Model" was published in the peer-reviewed journal's February 2018 issue.
Among subjects aged 18-60 years, there were no significant differences in hemagglutination-inhibition (HAI) titers between intradermal or
intramuscular injection. All subjects had titers of at least 1:40 for each influenza strain in the vaccine, and there were no significant differences in the mean fold increases in titers.
Children with congenital heart disease who were 24 months old or younger and were randomized to receive palivizumab instead of placebo received five doses by
intramuscular injection every 30 days (J.
Patients will be randomised to receive JVS-100 or placebo, administered via
intramuscular injection to the affected limb within 48 hours of the BTK revascularisation procedure and again three months later to evaluate the potential of JVS-100 to improve results.
Among subjects aged 18-60 years, there were no significant differences in hemagglutination-inhibition (HAI) titers between intradermal or
intramuscular injection. All subjects had titers of at least 1:40 in response to each of the influenza strains in the vaccine, and there were no significant differences in the mean fold increases in titers.
Patients in Kabul with cutaneous leishmaniasis were randomized to one of three treatment arms: 148 received 3-5 intralesional injections of stibogluconate using 2-7 mL doses that were spaced 5-7 days apart; 119 patients received a 20 mg/kg
intramuscular injection of stibogluconate daily for 21 days; and 139 patients were treated with a single application of thermotherapy at 50[degrees] C for 30 seconds at each treatment site.
Patients in Kabul with cutaneous leishmaniasis were randomized to one of three treatment arms: 148 received 3-5 intralesional injections of stibogluconate using 27 mL doses that were spaced 5-7 days apart; 119 patients received a 20 mg/kg
intramuscular injection of stibogluconate daily for 21 days; and 139 patients were treated with a single application of thermotherapy at 50[degrees] C for 30 seconds at each treatment site.
A single 1-mL
intramuscular injection inhibits ovulation for 12-14 weeks.
Infusion therapy might also be referred to as parenteral therapy, since the term "parenteral" refers to a substance that is taken into the body or administered in a manner other than through the digestive tract, such as by IV or
intramuscular injection.